https://genscriptprobio.com

End-to-End CDMO Service - ProBioProBio, Antibody CDMO, CDMOWe ProBio provide end-to-end CDMO service from drug discovery to commercialization in CGT, vaccine, biologics discovery and antibody protein drug with proactive strategies, professional solutions and efficient processes to accelerate drug development for customers.End-to-End CDMO Service - ProBio menu  Resource LibraryNew HandbooksNew Webinars Learning CenterNew About Us Company Introduction Experience & Expertise News & Activities Careers Partnership Customer Group Information Security Privacy Policy Cookies Policy Quality Management Capabilities & Capacity Regulatory Affairs Locations Contact Us SAP system Sign In Sign In Register My Account Sign Out EN > CN > JP JP > EN > CN × Biologics Discovery Antibody Lead Generation Hybridoma Generation for Therapeutic Antibody Discovery Single B Cell Screening Fully Human Antibody Discovery by Transgenic Mice Human Fab Naïve Library Solution for Novel Biologics Modalities Bispecific Antibody Discovery CAR Lead Discovery Single Domain Antibody Discovery ADC Discovery Service Hot! Antibody Discovery Solution for Multi-pass Membrane Targets New! pH-selective Antibody Discovery Service New! Antibody Lead Optimization Antibody Humanization Antibody Affinity Maturation Fc Engineering Service Developability Assessment Pharmacology & Discovery Reagent Service In Vitro Pharmacology In Vivo Pharmacology Anti-idiotype Antibody and Immunoassay Development Affinity Measurement Biologics CDMO Cell Line Development Fast Sample Preparation Cell Line Development ADCC Enhanced Cell Line Development Host Cell Commercial License GMP Cell Banking IND-enabling Study IND-enabling CMC Perfusion Process Development CMC Case Study Bioanalytical Development Antibody & Protein CMC Solutions for CGT Late-stage Process Development Process characterization & Process validation Clinical & Commercial Manufacturing 200-500L Drug Substance Manufacturing 2000L Drug Substance Manufacturing Aseptic Fill & Finish Technology Platforms ProBox™ Process Development Tool Box UproCHO™ Medium System Plasmid CDMO LentiHelper™ Plasmid Products AAssistV™ Plasmid Products Plasmid CMC for IND Plasmid Manufacture Linearized DNA Manufacture Lentiviral Vector CDMO Cell Line for LVV Manufacturing Cell Banking Service Lentiviral Vector One-stop solution LVV BLA PC/PV LVV Manufacturing Service AAV CDMO Cell Line for AAV Manufacturing AAV One-stop Solution AAV Manufacturing mRNA CDMO mRNA CMC for IND mRNA Manufacture Resource Library Handbooks Webinars About Us Company Introduction Experience & Expertise News & Activities Careers Partnership Customer Group Information Security Privacy Policy Cookies Policy Quality Management Capabilities & Capacity Regulatory Affairs Locations Contact Us Sign In Register My Account My Account Contact Information My Online Message Viewed Webinar Change password Sign Out Chinese Japan English Biologics Discovery Antibody Lead Generation Hybridoma Generation for Therapeutic Antibody Discovery Single B Cell Screening Fully Human Antibody Discovery by Transgenic Mice Human Fab Naïve Library New! Solution for Novel Biologics Modalities Bispecific Antibody Discovery CAR Lead Discovery Single Domain Antibody Discovery ADC Discovery Service Hot! Antibody Discovery Solution for Multi-pass Membrane Targets New! pH-selective Antibody Discovery Service New! Antibody Lead Optimization Antibody Humanization Antibody Affinity Maturation Fc Engineering Service Developability Assessment Pharmacology & Discovery Reagent Service In Vitro Pharmacology In Vivo Pharmacology Anti-idiotype Antibody and Immunoassay Development Affinity Measurement Biologics CDMO Cell Line Development Fast Sample Preparation Cell Line Development ADCC Enhanced Cell Line Development Host Cell Commercial License GMP Cell Banking IND-enabling Study IND-enabling CMC Perfusion Process Development CMC Case Study Bioanalytical Development Antibody & Protein CMC Solutions for CGT Late-stage Process Development Process characterization & Process validation Clinical & Commercial Manufacturing 200-500L Drug Substance Manufacturing 2000L Drug Substance Manufacturing Aseptic Fill & Finish Technology Platforms ProBox™ Process Development Tool Box UproCHO™ Medium System Plasmid CDMO LentiHelper™ Plasmid Products AAssistV™ Plasmid Products Plasmid CMC for IND Plasmid Manufacture Linearized DNA Manufacture Viral Vector CDMO Lentiviral Vector CDMO Cell Line for LVV Manufacturing Cell Banking Service Lentiviral Vector One-stop solution LVV BLA PC/PV LVV Manufacturing Service AAV CDMO Cell Line for AAV Manufacturing AAV One-stop Solution AAV Manufacturing mRNA CDMO mRNA CMC for IND mRNA Manufacture Congratulations! ProBio 's SAP system is online, accelerating digital transformation Learn More > Seminar Global Biologics Symposium 2024 - South Korea Date: 30th August, 2024 | Location: Gravity Seoul Pangyo, KR Learn more Proprietary PowerS™-ITRrs Strain √ Low ITR Recombination Rate & High Fermentation Yield √ Suitable for Different AAV Transfer Plasmids Learn more Fast CMC √ For mAb: 6 months from Sequence   to Tox batch completion √ For bsAb: 7 months from Sequence   to Tox batch completion Learn more Antibody & Protein CMC Solutions for CGT Flexible solutions for IIT material, IND material and GMP material As fast as 3.5 months from DNA to GMP material Learn more Previous Next Therapeutic Antibody Services Antibody Discovery Antibody Engineering & Characterization Antibody Drug Reagent Service IND-enabling Study Clinical Manufacturing Commercial Manufacturing CGT CDMO Clinical Plasmid Manufacturing GMP Plasmid Manufacturing Lentiviral Vector One-stop Solution GMP Lentiviral Vector Manufacturing Adeno-associated Viral Vector One-stop Solution Adeno-associated Viral Vector Manufacturing Our Advantages Quality Management ProBio developed the distinguishing Phase-appropriate Compliance (PAC) quality system to meet worldwide stringent regulatory standards (including US-FDA/EU-EMA/China-NMPA), which will benefit our customers in a way of high quality, cost-effectiveness, efficiency and credibility. Learn More » Experience & Expertise Our team and leaders have years of experience in global biopharma companies. Our PMs are trained scientists with PhD degree in the US and Europe. Learn More » Regulatory Affairs Probio RA team is committed to provide professional regulatory support on CMC development of biological products. We have confidence to provide strong support for your projects. Learn More » Capabilities & Capacity Current capacity: up to 20 CGT IND and 400 L biologics. Total 16,800 L bioreactors by 2023. Learn More » News & Activities Cooperation News Awards About ProBio ProBio – Biologics CDMO ProBio, a subsidiary of GenScript Biotech Corporation, offers end-to-end CDMO services from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in CGT, antibody and recombinant protein drug, aiming to accelerate drug development for customers. ProBio has established companies in the United States, the Netherlands, South Korea, and China (Hong Kong, Shanghai, and Nanjing) and other regions to serve global customers, and has helped customers in the United States, Europe, Asia Pacific and other regions obtain more than 90 IND approvals since October 2017. ProBio’s total CGT solution covers CMC of plasmid, viral vector, mRNA vaccine and nucleic acid drugs for IND filing as well as clinical manufacturing and commercial manufacturing. ProBio integrated CMC solution for plasmid and viral vector including cell banking, process development, characterization and validation, analytical method development and validation, and stability study to enable cell and gene therapy go to next milestone. ProBio’s innovative solutions for biologics discovery and development include therapeutic antibody discovery, antibody engineering and in vitro/ in vivo pharmacology studies. In the biologics CDMO service, ProBio has built a DNA to GMP material platform, including stable cell line development, host cell commercial license, process development, analytical development to clinical and commercial manufacturing, and offer fed-batch and perfusion processes to meet the growing needs for antibody and protein drugs. ProBio has established GMP capacity that meets regulatory requirements of the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and National Medical Products Administration (NMPA). Toward the mission of “Innovation through Collaboration”, ProBio is committed to helping customers shorten the timeline for the development of biological drugs from discovery to commercialization, significantly lowering R&D costs and shaping a healthier future. Partnership Navigation About Us News Careers Privacy Policy Cookies Policy CGT CDMO LentiHelper™ Plasmid Products GMPro™ Plasmid Manufacturing Lentiviral Vector One-stop Solution GMP LVV Manufacturing AAV one-stop solution Biologics Services Fully Human Antibody Discovery ProSpeed™ Single B Cell Antibody Discovery PK and ADA Assay Development Services Cell Line Development Service Preclinical CMC Service GMP Manufacturing Service Contact Us Tel：+1-732-885-9188 (US)         +86-400-025-8686(ext.3172) (CN) Email USA: [email protected] China: [email protected] APAC: [email protected] Europe: [email protected] Japan: [email protected] South Korea: [email protected]     Contact Us © 2023 ProBio All rights reserved. | 苏ICP备15037624号-6 | Site Map | Terms of Use and Privacy © 2023 ProBio All rights reserved. 苏ICP备15037624号-6 Site Map Terms of Use and Privacy1727376032https://genscriptprobio.com

ཁྱོད་རའི་ས་ཁོངས་ཞུན་དག་འབད་ག?

ཁྱོད༌ག༌ཅི༌འབདཝ༌སྨོ?